Tokyo, Japan

Satoshi Omura


Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Tokyo, JA (1976)
  • Minato-ku, JP (2003)

Company Filing History:


Years Active: 1976-2003

Loading Chart...
5 patents (USPTO):

Title: Satoshi Omura - Pioneering Innovator in Antibiotics and Pharmaceutical Research

Introduction:

Satoshi Omura, a Tokyo-based inventor and researcher, has made significant contributions to the field of antibiotics and pharmaceutical research. With an impressive track record of five patents under his name, Omura's work has played a pivotal role in advancing medical treatments and revolutionizing the healthcare industry.

Latest Patents:

Omura's most recent patents include the Roselipin derivative and the antibiotic OS-3256-B. The Roselipin derivative holds promise as a potential solution for combating various animal tumors, gram-positive bacteria, and other ailments. OS-3256-B, on the other hand, is an innovative azaamino acid derivative with remarkable inhibitory activities against leukemia L-1210, Sarcoma-180, and Hela cells.

Career Highlights:

With a rich background in the field, Omura has worked with esteemed organizations such as the Kitasato Institute and Nihon Tokushu Noyaku Seizo Kabushiki Kaisha, a prominent Japanese chemical firm. At the Kitasato Institute, Omura's groundbreaking research and discoveries in antibiotics garnered international recognition and acclaim.

Collaborations:

Omura has collaborated closely with notable coworkers, including Juichi Awaya and Toju Hata. Together, they have embarked on research projects aimed at exploring new frontiers in finding effective and safe treatment options in medicine. Such collaborations have resulted in groundbreaking inventions and advancements that continue to transform the pharmaceutical landscape.

Conclusion:

Satoshi Omura's contributions to the world of antibiotics and pharmaceutical research are phenomenal. Through his patented inventions, such as the Roselipin derivative and OS-3256-B, Omura has made significant strides in improving cancer treatment and infectious disease management. With each patent and collaboration, Omura's commitment to innovation and his relentless pursuit of excellence have truly established him as a pioneering force in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…